Published in Cancer Lett on December 09, 1997
Metabolic regulation of epigenetics. Cell Metab (2012) 2.55
Prolonged exposure to particulate pollution, genes associated with glutathione pathways, and DNA methylation in a cohort of older men. Environ Health Perspect (2011) 1.60
Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics (2010) 1.56
An epigenetic perspective on the free radical theory of development. Free Radic Biol Med (2007) 1.35
Epigenetic effects of ethanol on liver and gastrointestinal injury. World J Gastroenterol (2006) 1.29
The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxid Redox Signal (2011) 1.24
Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal (2009) 1.11
Interactions between epigenetics and metabolism in cancers. Front Oncol (2012) 1.11
Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radic Biol Med (2009) 1.10
Interplay between cellular methyl metabolism and adaptive efflux during oncogenic transformation from chronic arsenic exposure in human cells. J Biol Chem (2008) 1.06
Hypothesis: a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation. Environ Health Perspect (2009) 1.06
Epigenetic targets for reversing immune defects caused by alcohol exposure. Alcohol Res (2013) 0.96
Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential. PLoS One (2012) 0.94
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. BMC Med (2014) 0.92
Glutathione redox dynamics and expression of glutathione-related genes in the developing embryo. Free Radic Biol Med (2013) 0.89
Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis (2015) 0.86
Epigenetic factors in cancer risk: effect of chemical carcinogens on global DNA methylation pattern in human TK6 cells. PLoS One (2012) 0.86
Hydroquinone increases 5-hydroxymethylcytosine formation through ten eleven translocation 1 (TET1) 5-methylcytosine dioxygenase. J Biol Chem (2013) 0.86
Redox regulation of the epigenetic landscape in cancer: a role for metabolic reprogramming in remodeling the epigenome. Free Radic Biol Med (2012) 0.85
Cancer drug resistance: redox resetting renders a way. Oncotarget (2016) 0.84
Role of a redox-based methylation switch in mRNA life cycle (pre- and post-transcriptional maturation) and protein turnover: implications in neurological disorders. Front Neurosci (2012) 0.80
Blood glutathione redox status and global methylation of peripheral blood mononuclear cell DNA in Bangladeshi adults. Epigenetics (2013) 0.79
Oxidative stress signaling to chromatin in health and disease. Epigenomics (2016) 0.76
Metabolic control of the epigenome in systemic Lupus erythematosus. Autoimmunity (2013) 0.76
Alcohol Modulation of the Postburn Hepatic Response. J Burn Care Res (2015) 0.75
Ischaemic colitis. Gut (1966) 5.51
The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med (1997) 5.07
Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell (1993) 4.06
Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies. Immunol Rev (1983) 3.70
Frequency and distribution in the United States of strains of Neisseria gonorrhoeae with plasmid-mediated, high-level resistance to tetracycline. J Infect Dis (1987) 3.62
CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol (1994) 3.50
The iliac compression syndrome. Br J Surg (1965) 3.40
Caudal additives in children--solutions or problems? Br J Anaesth (2003) 3.39
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. J Infect Dis (1981) 3.28
Structural variants of human T200 glycoprotein (leukocyte-common antigen). EMBO J (1987) 3.19
Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell (1993) 3.07
Evidence for presence of an internal thiolester bond in third component of human complement. Proc Natl Acad Sci U S A (1980) 3.00
Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol (1986) 2.80
A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science (1995) 2.68
Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell (1989) 2.62
MRC OX-19: a monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses. Eur J Immunol (1984) 2.56
Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature (1990) 2.51
Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol Cell Biol (1992) 2.48
Evidence from cDNA clones that the rat leukocyte-common antigen (T200) spans the lipid bilayer and contains a cytoplasmic domain of 80,000 Mr. Cell (1985) 2.43
Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity (1997) 2.34
Relation between postphlebitic changes in the deep veins and results of surgical treatment of venous ulcers. Lancet (1976) 2.31
Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis. Antimicrob Agents Chemother (1980) 2.27
Xanthogranulomatous pyelonephritis: experience in 36 cases. J Urol (1992) 2.02
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. J Pediatr (1981) 2.00
Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science (1996) 1.99
A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation. Proc Natl Acad Sci U S A (2000) 1.89
B-cell variant of mouse T200 (Ly-5): evidence for alternative mRNA splicing. Proc Natl Acad Sci U S A (1987) 1.85
Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des (2008) 1.82
Coronary artery ectasia--a variant of occlusive coronary arteriosclerosis. Br Heart J (1978) 1.78
Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med (2000) 1.76
Separation of Treponema pallidum from tissue substances by continuous-flow zonal centrifugation. Appl Microbiol (1972) 1.72
Differential expression of the leucocyte-common antigen family. Immunol Today (1988) 1.70
Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children. Pediatrics (1979) 1.65
Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial. Br Med J (Clin Res Ed) (1987) 1.62
The relative importance of incompetent communicating veins in the production of varicose veins and venous ulcers. Surgery (1977) 1.59
Cellular fatty acids of nonpathogenic Neisseria. Can J Microbiol (1971) 1.57
Ultrasonography for inguinal hernias in boys. J Pediatr Surg (1998) 1.55
Portfolio learning in general practice vocational training--does it work? Med Educ (1998) 1.55
Identification of an additional member of the protein-tyrosine-phosphatase family: evidence for alternative splicing in the tyrosine phosphatase domain. Proc Natl Acad Sci U S A (1990) 1.55
Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc Natl Acad Sci U S A (1993) 1.54
Estrogen receptor-alpha detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology (1999) 1.53
Hypersensitization of tumor cells to glycolytic inhibitors. Biochemistry (2001) 1.52
B-cell depletion extends the survival of GTKO.hCD46Tg pig heart xenografts in baboons for up to 8 months. Am J Transplant (2011) 1.51
Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature (1996) 1.47
The relationship between the number of capillaries in the skin of the venous ulcer-bearing area of the lower leg and the fall in foot vein pressure during exercise. Br J Surg (1981) 1.43
Retrograde transcatheter occlusion of patent ductus arteriosus: preliminary experience in Gianturco coil technique without heparinization. J Invasive Cardiol (2001) 1.42
Design of antineoplastic agents on the basis of the "2-phenylnaphthalene-type" structural pattern. 2. Synthesis and biological activity studies of benzo]b]naphtho[2,3-d]furan-6,11-dione derivatives. J Med Chem (1993) 1.41
Detection of occult bone metastasis by MRI scan. J Fla Med Assoc (1990) 1.40
Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability. Pediatrics (1978) 1.39
Different classes of T lymphocytes have different mRNAs for the leukocyte-common antigen, T200. J Exp Med (1986) 1.39
Streptokinase and deep vein thrombosis. Br Med J (1968) 1.38
Management of the source of pulmonary emboli: the value of phlebography. Br Med J (1967) 1.36
Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism. Br Med J (1974) 1.35
Venous collaterals in external and common iliac vein obstruction. Clin Radiol (1967) 1.32
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia. Proc Natl Acad Sci U S A (2001) 1.30
Discrepancy between carbenicillin and ampicillin activities against enterococci and Listeria. Antimicrob Agents Chemother (1973) 1.29
Molecular nature of the W3/25 and MRC OX-8 marker antigens for rat T lymphocytes: comparisons with mouse and human antigens. Eur J Immunol (1983) 1.28
AN IMMUNOLOGICAL STUDY OF THE A SUBSTANCE OR ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I. J Exp Med (1934) 1.27
Influence of ovarian hormones and estrous cycle on the behavioral response to cocaine in female rats. J Pharmacol Exp Ther (2000) 1.26
Primary angioplasty in acute inferior myocardial infarction with anomalous-origin right coronary arteries as infarct-related arteries: focus on anatomic and clinical features, outcomes, selection of guiding catheters and management. J Invasive Cardiol (2001) 1.25
HLA sharing and spontaneous abortion in humans. Am J Obstet Gynecol (1985) 1.25
Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation. Int J Radiat Biol (1999) 1.24
Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood (2001) 1.24
Bone disease in burn patients. J Bone Miner Res (1993) 1.23
Phlebography. Arch Surg (1972) 1.23
Death from fat embolism as a complication of intraosseous phlebography. Lancet (1973) 1.21
The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res (1977) 1.20
Third component of human complement: localization of the internal thiolester bond. Proc Natl Acad Sci U S A (1982) 1.20
The protein tyrosine phosphatase SHP-1 regulates integrin-mediated adhesion of macrophages. Curr Biol (1998) 1.19
Sequence determination of the thiolester site of the fourth component of human complement. Proc Natl Acad Sci U S A (1981) 1.19
Pharmacologic studies in neonates given large dosages of ampicillin. J Pediatr (1974) 1.19
One-year heterotopic cardiac xenograft survival in a pig to baboon model. Am J Transplant (2013) 1.19
Pharmacologic evaluation of gentamicin in newborn infants. J Infect Dis (1971) 1.17
Prevention of recurrent pulmonary embolism. Br Med J (1969) 1.17
Binding of C3b proceeds by a transesterification reaction at the thiolester site. Nature (1982) 1.17
Pharmacokinetics of cefaclor in infants and children. J Antimicrob Chemother (1978) 1.16
Cerebral hereditary haemorrhagic telangiectasia demonstrated angiographically. Australas Radiol (1975) 1.16
Simplified phlebography in deep venous thrombosis. Clin Radiol (1971) 1.15
Source of non-lethal pulmonary emboli. Lancet (1974) 1.14
Is the postphlebitic leg always postphlebitic? Relation between phlebographic appearances of deep-vein thrombosis and late sequelae. Br Med J (1980) 1.14
Post-thrombotic inferior vena caval obstruction. A review of 24 patients. Br Med J (1970) 1.12
Compression and band formation at the mouth of the left common iliac vein. Br J Surg (1968) 1.12
Portfolio-based learning and general practice vocational training. Med Educ (1996) 1.11
CD8+ T-cell clones deficient in the expression of the CD45 protein tyrosine phosphatase have impaired responses to T-cell receptor stimuli. Mol Cell Biol (1991) 1.11
Kidney function after renal arterial embolism. Br Med J (1969) 1.10
Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge. Biochemistry (1997) 1.10
Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan. Lupus (2009) 1.10
Polyhydramnios: ultrasonically detected prevalence and neonatal outcome. Obstet Gynecol (1987) 1.09
Drug resistance in brain tumors. J Neurooncol (1994) 1.08
Clinical pharmacology of cefadroxil in infants and children. Antimicrob Agents Chemother (1978) 1.06
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer (2012) 1.06
NH2-terminal structure and cleavage of guinea pig pro-C3, the precursor of the third complement component. J Biol Chem (1981) 1.05
Definition of family of coronin-related proteins conserved between humans and mice: close genetic linkage between coronin-2 and CD45-associated protein. DNA Cell Biol (1998) 1.05
Entry of B cell receptor into signaling domains is inhibited in tolerant B cells. J Exp Med (2000) 1.04
Purification and characterization of the human interferon-gamma receptor from placenta. Proc Natl Acad Sci U S A (1988) 1.04